US 11,946,045 B2
Compositions comprising a variant polypeptide and uses thereof
Shaorong Chong, Arlington, MA (US); Wei-Cheng Lu, Cambridge, MA (US); Brendan Jay Hilbert, Natick, MA (US); Quinton Norman Wessells, Cambridge, MA (US); Lauren E. Alfonse, Boston, MA (US); and Anthony James Garrity, Hingham, MA (US)
Assigned to Arbor Biotechnologies, Inc., Cambridge, MA (US)
Filed by Arbor Biotechnologies, Inc., Cambridge, MA (US)
Filed on Dec. 30, 2022, as Appl. No. 18/148,748.
Application 18/148,748 is a continuation of application No. PCT/US2022/019525, filed on Mar. 9, 2022.
Claims priority of provisional application 63/176,021, filed on Apr. 16, 2021.
Claims priority of provisional application 63/158,738, filed on Mar. 9, 2021.
Prior Publication US 2023/0287403 A1, Sep. 14, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 15/11 (2006.01); C12N 9/22 (2006.01)
CPC C12N 15/11 (2013.01) [C12N 9/22 (2013.01); C12N 2310/20 (2017.05)] 23 Claims
 
1. A variant polypeptide comprising the sequence set forth in SEQ ID NO: 51.